EUVIMEDEUVIMED entdecken
Crossref

Effect of combination versus sequential teriparatide initiation on vertebral bone marrow microenvironment in postmenopausal women with prior denosumab treatment: A propensity score-matched study

Jie Hao, Fayao Yan, Yu Yao, Tongrui Zhang, Yongqi Zhang, Zheng Li, Hao Xu, Xingjie Jiang

Bone · 2026-10 · 211 · 117955

DOI: 10.1016/j.bone.2026.117955 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bone, 2026-10. Verfasst von Jie Hao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Spine Surgery, Department of Orthopedic Surgery, Affiliated Hospital of Nantong University, Nantong, China. Electronic address: haojie199…. Hauptthemen laut MEDLINE: Denosumab, Teriparatide, Bone Marrow, Spine. Die Arbeit nennt 36 Literaturangaben. Gefördert von: Science and Technology Project of Nantong City, Nantong University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The optimal strategy for transitioning from long-term denosumab (DMAb) to teriparatide (TPTD) in postmenopausal osteoporosis remains a clinical dilemma, as DMAb withdrawal can trigger a deleterious rebound in bone resorption. While bone mineral density (BMD) is the traditional benchmark, it fails to capture critical aspects of bone quality, such as the bone marrow microenvironment. This study investigated whether the method of TPTD initiation-adding it to ongoing DMAb (combination) versus switching after DMAb withdrawal (sequential)-differentially affects the vertebral bone marrow microenvironment, assessed by the MRI-derived vertebral bone quality (VBQ) score, a novel marker of marrow adiposity. METHODS: In this retrospective cohort study, postmenopausal women with osteoporosis who received TPTD for ≥12 months after at least 24 months of DMAb were included. Propensity score matching (1:1) yielded 60 patients in the combination group and 60 in the sequential group. The primary outcome was the percentage change in VBQ (ΔVBQ%) from baseline to 12 months. RESULTS: Combination therapy resulted in a significant improvement in the bone marrow microenvironment (ΔVBQ%: -7.1% ± 3.0%), whereas sequential therapy did not (-0.5% ± 5.4%), with an adjusted between-group difference of -6.5% (95%CI: -8.1 to -4.9, P < 0.001). This was accompanied by superior gains in lumbar spine BMD (+9.4% vs. +5.6%, P < 0.001) and trabecular bone score (+4.8% vs. +1.5%, P < 0.001). Notably, the combination group maintained complete suppression of bone resorption (CTX), while the sequential group experienced a marked and sustained CTX rebound. Furthermore, in the combination group, the improvement in VBQ was significantly correlated with early bone formation activation (ΔPINP at M + 3, r = -0.50) and with gains in lumbar spine BMD (r = -0.40) and TBS (r = -0.77), suggesting a mechanistic link between modeling-based bone formation and microenvironmental restoration. CONCLUSIONS: In postmenopausal women with long-term prior denosumab treatment, initiating teriparatide while continuing denosumab was associated with significantly greater improvement in the vertebral bone marrow microenvironment (greater VBQ reduction), more consistent gains in lumbar spine BMD and TBS, and better control of bone resorption markers over 12 months compared with a sequential switch after denosumab withdrawal. These findings suggest that the combination strategy may be more favorable than a sequential switch for improving vertebral bone quality. While our data provide mechanistic support for current guideline recommendations, confirmation in prospective randomized studies is required before clinical translation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DenosumabTeriparatideBone MarrowSpinePostmenopauseCellular MicroenvironmentOsteoporosis, PostmenopausalHumansFemaleAgedRetrospective StudiesPropensity ScoreMiddle AgedBone DensityDrug Therapy, CombinationBone Density Conservation Agents

Stichwörter der Autor:innen

Bone marrow microenvironmentCombination therapyDenosumabTeriparatideVertebral bone quality (VBQ)

Substanzen

DenosumabTeriparatideBone Density Conservation Agents

Autor:innen und Institutionen

  • Division of Spine Surgery, Department of Orthopedic Surgery, Affiliated Hospital of Nantong University, Nantong, China. Electronic address: haojie1991@163.com.
  • Division of Spine Surgery, Department of Orthopedic Surgery, Affiliated Hospital of Nantong University, Nantong, China. Electronic address: y13851175383@163.com.
  • Division of Spine Surgery, Department of Orthopedic Surgery, Affiliated Hospital of Nantong University, Nantong, China. Electronic address: yaoyu1122@sina.com.
  • Division of Spine Surgery, Department of Orthopedic Surgery, Affiliated Hospital of Nantong University, Nantong, China. Electronic address: 1052515859@qq.com.
  • Division of Spine Surgery, Department of Orthopedic Surgery, Affiliated Hospital of Nantong University, Nantong, China. Electronic address: 1847906933@qq.com.
  • Affiliated Qidong Hospital of Nantong University/Qidong People's Hospital/Qidong Liver Cancer Institute, Nantong, Jiangsu, 226200,China. Electronic address: 632630245@qq.com.

Förderung

  • Science and Technology Project of Nantong City
  • Nantong University

Zitieren

APA

Hao, J., Yan, F., Yao, Y., Zhang, T., Zhang, Y., Li, Z., Xu, H., & Jiang, X. (2026). Effect of combination versus sequential teriparatide initiation on vertebral bone marrow microenvironment in postmenopausal women with prior denosumab treatment: A propensity score-matched study. Bone, 211, 117955. https://doi.org/10.1016/j.bone.2026.117955

Vancouver

Hao J, Yan F, Yao Y, Zhang T, Zhang Y, Li Z, et al. Effect of combination versus sequential teriparatide initiation on vertebral bone marrow microenvironment in postmenopausal women with prior denosumab treatment: A propensity score-matched study. Bone. 2026;211:117955. doi:10.1016/j.bone.2026.117955

BibTeX
@article{Hao2026,
  author = {Hao, Jie and Yan, Fayao and Yao, Yu and Zhang, Tongrui and Zhang, Yongqi and Li, Zheng and Xu, Hao and Jiang, Xingjie},
  title = {Effect of combination versus sequential teriparatide initiation on vertebral bone marrow microenvironment in postmenopausal women with prior denosumab treatment: A propensity score-matched study},
  journal = {Bone},
  year = {2026},
  volume = {211},
  pages = {117955},
  doi = {10.1016/j.bone.2026.117955}
}
Kostenlos starten →